DK0950062T3 - Proteinmarkörer for esophageal cancer - Google Patents
Proteinmarkörer for esophageal cancerInfo
- Publication number
- DK0950062T3 DK0950062T3 DK97927689T DK97927689T DK0950062T3 DK 0950062 T3 DK0950062 T3 DK 0950062T3 DK 97927689 T DK97927689 T DK 97927689T DK 97927689 T DK97927689 T DK 97927689T DK 0950062 T3 DK0950062 T3 DK 0950062T3
- Authority
- DK
- Denmark
- Prior art keywords
- esophageal cancer
- protein markers
- proteins
- tissue
- ipg
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
- G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1865996P | 1996-05-30 | 1996-05-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0950062T3 true DK0950062T3 (da) | 2006-08-14 |
Family
ID=21789115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97927689T DK0950062T3 (da) | 1996-05-30 | 1997-05-29 | Proteinmarkörer for esophageal cancer |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0950062B1 (da) |
| JP (1) | JP4993799B2 (da) |
| AT (1) | ATE323103T1 (da) |
| AU (1) | AU739306B2 (da) |
| CA (1) | CA2264963C (da) |
| DE (1) | DE69735676T2 (da) |
| DK (1) | DK0950062T3 (da) |
| ES (1) | ES2258278T3 (da) |
| NZ (1) | NZ333075A (da) |
| WO (1) | WO1997045445A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002951153A0 (en) * | 2002-09-02 | 2002-09-19 | Proteome Systems Intellectual Property Pty Ltd | An electrophoresis gel having improved swelling properties |
| JPWO2005093063A1 (ja) * | 2004-03-29 | 2008-02-14 | 株式会社医学生物学研究所 | 固形癌診断キット及び固形癌治療用医薬 |
| WO2005118811A1 (ja) | 2004-06-02 | 2005-12-15 | Tss Biotech Inc. | 癌の診断と治療において有用な新規ポリペプチド |
| GB0521521D0 (en) * | 2005-10-21 | 2005-11-30 | Medical Res Council | Diagnostic methods and kits |
| CN102089428B (zh) | 2008-05-21 | 2013-11-13 | 东丽株式会社 | 食道癌确定用组合物及方法 |
-
1997
- 1997-05-29 WO PCT/US1997/008656 patent/WO1997045445A1/en not_active Ceased
- 1997-05-29 ES ES97927689T patent/ES2258278T3/es not_active Expired - Lifetime
- 1997-05-29 DE DE69735676T patent/DE69735676T2/de not_active Expired - Lifetime
- 1997-05-29 AT AT97927689T patent/ATE323103T1/de not_active IP Right Cessation
- 1997-05-29 NZ NZ333075A patent/NZ333075A/xx not_active IP Right Cessation
- 1997-05-29 CA CA002264963A patent/CA2264963C/en not_active Expired - Fee Related
- 1997-05-29 JP JP54270697A patent/JP4993799B2/ja not_active Expired - Fee Related
- 1997-05-29 AU AU32089/97A patent/AU739306B2/en not_active Ceased
- 1997-05-29 DK DK97927689T patent/DK0950062T3/da active
- 1997-05-29 EP EP97927689A patent/EP0950062B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69735676T2 (de) | 2006-10-19 |
| JP4993799B2 (ja) | 2012-08-08 |
| NZ333075A (en) | 2000-05-26 |
| JP2000511536A (ja) | 2000-09-05 |
| EP0950062B1 (en) | 2006-04-12 |
| ES2258278T3 (es) | 2006-08-16 |
| CA2264963A1 (en) | 1997-12-04 |
| ATE323103T1 (de) | 2006-04-15 |
| DE69735676D1 (de) | 2006-05-24 |
| EP0950062A4 (en) | 2000-07-05 |
| AU739306B2 (en) | 2001-10-11 |
| WO1997045445A1 (en) | 1997-12-04 |
| CA2264963C (en) | 2010-03-09 |
| EP0950062A1 (en) | 1999-10-20 |
| AU3208997A (en) | 1998-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0961780T3 (da) | Proteinmarkörer for lungecancer og anvendelse deraf | |
| WO1998035985B1 (en) | Protein markers for lung cancer and use thereof | |
| TR199902818T2 (xx) | Be�eri kullan�m i�in antikorlar ve be�eri kullan�m i�in antikorlar olu�turmak i�in y�ntemler. | |
| ATE347360T1 (de) | Verfahren zur induktion von krebszellentod und tumorregression | |
| DE69428764D1 (de) | Immunokonjugate | |
| FR07C0017I2 (fr) | Anticorps anti-vegf | |
| BR0315666A (pt) | Dna de a34 e a33 do tipo 3, proteìnas, seus anticorpos e métodos de tratamento usando os mesmos | |
| NO961115L (no) | Humane metabotrope glutamatreseptorsubtyper (HMR4, HMR6, HMR7) og relaterte DNA forbindelser | |
| DE69833014D1 (de) | Menschliche toll homologen | |
| ES2141249T3 (es) | Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores. | |
| EP0772625A4 (en) | Oligonucleoside compounds and methods for inhibiting tumor growth, invasion and metastasis | |
| DE60044350D1 (de) | Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs | |
| DK0950062T3 (da) | Proteinmarkörer for esophageal cancer | |
| DK0833948T3 (da) | Tyktarmspecifikt gen og protein | |
| DE69636041D1 (de) | Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen | |
| AU5298696A (en) | Tumor marker protein for cancer risk assessment | |
| DE69019410D1 (de) | Retinoblastoma-Genprodukt-Antikörper und deren Verwendungen. | |
| BR0012301A (pt) | Inibidores de crescimento de células epiteliais | |
| DE59712604D1 (de) | Mittel zur identifizierung und therapie metastasierender tumore | |
| WO2001059114A3 (en) | Tumor suppressor gene, p47ing3 | |
| WO2003054008A3 (en) | Mammalian simp protein, gene sequence and uses thereof in cancer therapy |